PIGF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.492000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.452300E-02
Normal-vs-Stage2
3.654800E-01
Normal-vs-Stage3
5.612000E-01
Normal-vs-Stage4
2.285600E-01
Stage1-vs-Stage2
2.731600E-01
Stage1-vs-Stage3
3.734300E-02
Stage1-vs-Stage4
4.196200E-01
Stage2-vs-Stage3
6.495600E-02
Stage2-vs-Stage4
8.836200E-01
Stage3-vs-Stage4
1.313580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.439400E-01
Normal-vs-AfricanAmerican
4.399200E-01
Normal-vs-Asian
9.426200E-01
Caucasian-vs-AfricanAmerican
7.626000E-01
Caucasian-vs-Asian
8.986500E-02
AfricanAmerican-vs-Asian
2.642400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.516200E-01
Normal-vs-Female
3.648600E-01
Male-vs-Female
7.915400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.745560E-01
Normal-vs-Age(41-60Yrs)
1.919980E-01
Normal-vs-Age(61-80Yrs)
5.166400E-01
Normal-vs-Age(81-100Yrs)
1.710810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.984000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.329400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.359600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.224000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.351800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.992600E-01
Normal-vs-Daily Drinker
4.444800E-01
Normal-vs-Weekly Drinker
7.787800E-01
Normal-vs-Occasional Drinker
1.405590E-01
Normal-vs-Social Drinker
2.725200E-01
Non Drinker-vs-Daily Drinker
3.276600E-01
Non Drinker-vs-Weekly Drinker
8.350800E-01
Non Drinker-vs-Occasional Drinker
2.329500E-02
Non Drinker-vs-Social Drinker
3.027400E-01
Daily Drinker-vs-Weekly Drinker
3.962600E-01
Daily Drinker-vs-Occasional Drinker
3.212800E-01
Daily Drinker-vs-Social Drinker
9.816800E-01
Weekly Drinker-vs-Occasional Drinker
7.570200E-02
Weekly Drinker-vs-Social Drinker
3.634600E-01
Occasional Drinker-vs-Social Drinker
2.579600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.977500E-02
Normal-vs-Grade 2
4.756100E-02
Normal-vs-Grade 3
2.497700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.739800E-01
Grade 1-vs-Grade 3
3.980200E-01
Grade 1-vs-Grade 4
5.977500E-02
Grade 2-vs-Grade 3
1.934420E-01
Grade 2-vs-Grade 4
4.756100E-02
Grade 3-vs-Grade 4
2.497700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.208400E-01
Normal-vs-NonDiabetic
3.809200E-01
Diabetic-vs-NonDiabetic
5.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.962200E-01
Normal-vs-NoPancreatitis
3.812200E-01
Pancreatitis-vs-NoPancreatitis
6.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.643600E-01
Normal-vs-N1
3.503200E-01
N0-vs-N1
6.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.771800E-01
Normal-vs-TP53-NonMutant
3.588400E-01
TP53-Mutant-vs-TP53-NonMutant
5.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
